Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Jul;80(9):1322–1331. doi: 10.1038/sj.bjc.6690525

Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours

J C Nicholson 1,2, F M Ross 1, J A Kohler 2, D W Ellison 3
PMCID: PMC2363061  PMID: 10424732

Abstract

The objective of this study was to test the hypothesis that chromosomal imbalances in central nervous system primitive neuroectodermal tumours (PNETs) reflect site and histology. We used comparative genomic hybridization to study 37 cases of PNET, of which four were cerebral and 31 were medulloblastomas classified histologically as classic (n = 17) or nodular/desmoplastic (n = 14). Tumour immunophenotype was characterized with antibodies to neuroglial, mesenchymal and epithelial markers. Chromosomal imbalances were detected in 28 medulloblastomas (90%), and significant associations between tumour variants and genetic abnormalities were demonstrated. Aberrations suggesting isochromosome 17q were present in eight (26%) medulloblastomas, of which seven were classic variants. None of these cases, or a further six with gain of 17q, showed immunoreactivity for glial fibrillary acidic protein. Loss on 9q was found in six cases (19%), five of them nodular/desmoplastic. Loss of 22 occurred in four (13%), all classic medulloblastomas in young patients with a poor outcome and immunoreactivity for more than one epithelial or mesenchymal marker. Different patterns of imbalance were found in the cerebral PNETs. There were no abnormalities of chromosome 17, but all three cases with imbalance showed losses of 3p12.3–p14. © 1999 Cancer Research Campaign

Keywords: medulloblastoma, cerebral PNET, comparative genomic hybridization, isochromosome 17q, monosomy 22, glial fibrillary acidic protein

Full Text

The Full Text of this article is available as a PDF (135.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey C. C., Gnekow A., Wellek S., Jones M., Round C., Brown J., Phillips A., Neidhardt M. K. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol. 1995 Sep;25(3):166–178. doi: 10.1002/mpo.2950250303. [DOI] [PubMed] [Google Scholar]
  2. Batra S. K., McLendon R. E., Koo J. S., Castelino-Prabhu S., Fuchs H. E., Krischer J. P., Friedman H. S., Bigner D. D., Bigner S. H. Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol. 1995;24(1):39–45. doi: 10.1007/BF01052657. [DOI] [PubMed] [Google Scholar]
  3. Batra S. K., Rasheed B. K., Bigner S. H., Bigner D. D. Oncogenes and anti-oncogenes in human central nervous system tumors. Lab Invest. 1994 Nov;71(5):621–637. [PubMed] [Google Scholar]
  4. Bhattacharjee M. B., Armstrong D. D., Vogel H., Cooley L. D. Cytogenetic analysis of 120 primary pediatric brain tumors and literature review. Cancer Genet Cytogenet. 1997 Aug;97(1):39–53. doi: 10.1016/s0165-4608(96)00330-5. [DOI] [PubMed] [Google Scholar]
  5. Biegel J. A., Rorke L. B., Janss A. J., Sutton L. N., Parmiter A. H. Isochromosome 17q demonstrated by interphase fluorescence in situ hybridization in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer. 1995 Oct;14(2):85–96. doi: 10.1002/gcc.2870140202. [DOI] [PubMed] [Google Scholar]
  6. Biegel J. A., Rorke L. B., Packer R. J., Emanuel B. S. Monosomy 22 in rhabdoid or atypical tumors of the brain. J Neurosurg. 1990 Nov;73(5):710–714. doi: 10.3171/jns.1990.73.5.0710. [DOI] [PubMed] [Google Scholar]
  7. Biegel J. A., Rorke L. B., Packer R. J., Sutton L. N., Schut L., Bonner K., Emanuel B. S. Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer. 1989 Nov;1(2):139–147. doi: 10.1002/gcc.2870010206. [DOI] [PubMed] [Google Scholar]
  8. Bigner S. H., McLendon R. E., Fuchs H., McKeever P. E., Friedman H. S. Chromosomal characteristics of childhood brain tumors. Cancer Genet Cytogenet. 1997 Sep;97(2):125–134. doi: 10.1016/s0165-4608(96)00404-9. [DOI] [PubMed] [Google Scholar]
  9. Bigner S. H., Vogelstein B. Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathol. 1990 Sep;1(1):12–18. doi: 10.1111/j.1750-3639.1990.tb00633.x. [DOI] [PubMed] [Google Scholar]
  10. Blaeker H., Rasheed B. K., McLendon R. E., Friedman H. S., Batra S. K., Fuchs H. E., Bigner S. H. Microsatellite analysis of childhood brain tumors. Genes Chromosomes Cancer. 1996 Jan;15(1):54–63. doi: 10.1002/(SICI)1098-2264(199601)15:1<54::AID-GCC8>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  11. Brenner M. Structure and transcriptional regulation of the GFAP gene. Brain Pathol. 1994 Jul;4(3):245–257. doi: 10.1111/j.1750-3639.1994.tb00840.x. [DOI] [PubMed] [Google Scholar]
  12. Burnett M. E., White E. C., Sih S., von Haken M. S., Cogen P. H. Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. Cancer Genet Cytogenet. 1997 Aug;97(1):25–31. doi: 10.1016/s0165-4608(96)00319-6. [DOI] [PubMed] [Google Scholar]
  13. Choux M., Lena G., Hassoun J. Prognosis and long-term follow-up in patients with medulloblastoma. Clin Neurosurg. 1983;30:246–277. doi: 10.1093/neurosurgery/30.cn_suppl_1.246. [DOI] [PubMed] [Google Scholar]
  14. Cogen P. H., Daneshvar L., Metzger A. K., Edwards M. S. Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics. 1990 Oct;8(2):279–285. doi: 10.1016/0888-7543(90)90283-z. [DOI] [PubMed] [Google Scholar]
  15. Ellison D. W., Steart P. V., Gatter K. C., Weller R. O. Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropathol Appl Neurobiol. 1995 Aug;21(4):352–361. doi: 10.1111/j.1365-2990.1995.tb01070.x. [DOI] [PubMed] [Google Scholar]
  16. Emadian S. M., McDonald J. D., Gerken S. C., Fults D. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma. Clin Cancer Res. 1996 Sep;2(9):1559–1564. [PubMed] [Google Scholar]
  17. Fazioli F., Minichiello L., Matoska V., Castagnino P., Miki T., Wong W. T., Di Fiore P. P. Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. EMBO J. 1993 Oct;12(10):3799–3808. doi: 10.1002/j.1460-2075.1993.tb06058.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Geyer J. R., Zeltzer P. M., Boyett J. M., Rorke L. B., Stanley P., Albright A. L., Wisoff J. H., Milstein J. M., Allen J. C., Finlay J. L. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin Oncol. 1994 Aug;12(8):1607–1615. doi: 10.1200/JCO.1994.12.8.1607. [DOI] [PubMed] [Google Scholar]
  19. Giangaspero F., Chieco P., Ceccarelli C., Lisignoli G., Pozzuoli R., Gambacorta M., Rossi G., Burger P. C. "Desmoplastic" versus "classic" medulloblastoma: comparison of DNA content, histopathology and differentiation. Virchows Arch A Pathol Anat Histopathol. 1991;418(3):207–214. doi: 10.1007/BF01606058. [DOI] [PubMed] [Google Scholar]
  20. Gilbertson R. J., Perry R. H., Kelly P. J., Pearson A. D., Lunec J. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res. 1997 Aug 1;57(15):3272–3280. [PubMed] [Google Scholar]
  21. Hubbard J. L., Scheithauer B. W., Kispert D. B., Carpenter S. M., Wick M. R., Laws E. R., Jr Adult cerebellar medulloblastomas: the pathological, radiographic, and clinical disease spectrum. J Neurosurg. 1989 Apr;70(4):536–544. doi: 10.3171/jns.1989.70.4.0536. [DOI] [PubMed] [Google Scholar]
  22. Janss A. J., Yachnis A. T., Silber J. H., Trojanowski J. Q., Lee V. M., Sutton L. N., Perilongo G., Rorke L. B., Phillips P. C. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors. Ann Neurol. 1996 Apr;39(4):481–489. doi: 10.1002/ana.410390410. [DOI] [PubMed] [Google Scholar]
  23. Jaros E., Lunec J., Perry R. H., Kelly P. J., Pearson A. D. p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis. Br J Cancer. 1993 Oct;68(4):801–807. doi: 10.1038/bjc.1993.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kallioniemi O. P., Kallioniemi A., Piper J., Isola J., Waldman F. M., Gray J. W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 1994 Aug;10(4):231–243. doi: 10.1002/gcc.2870100403. [DOI] [PubMed] [Google Scholar]
  25. Maraziotis T., Perentes E., Karamitopoulou E., Nakagawa Y., Gessaga E. C., Probst A., Frankfurter A. Neuron-associated class III beta-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: a clinicopathological analysis of 36 cases. Acta Neuropathol. 1992;84(4):355–363. doi: 10.1007/BF00227661. [DOI] [PubMed] [Google Scholar]
  26. McDonald J. D., Daneshvar L., Willert J. R., Matsumura K., Waldman F., Cogen P. H. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics. 1994 Sep 1;23(1):229–232. doi: 10.1006/geno.1994.1481. [DOI] [PubMed] [Google Scholar]
  27. Mertens F., Johansson B., Mitelman F. Isochromosomes in neoplasia. Genes Chromosomes Cancer. 1994 Aug;10(4):221–230. doi: 10.1002/gcc.2870100402. [DOI] [PubMed] [Google Scholar]
  28. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Packer R. J. Brain tumors in children. Curr Opin Pediatr. 1995 Feb;7(1):64–72. doi: 10.1097/00008480-199502000-00012. [DOI] [PubMed] [Google Scholar]
  30. Phelan C. M., Liu L., Ruttledge M. H., Müntzning K., Ridderheim P. A., Collins V. P. Chromosome 17 abnormalities and lack of TP53 mutations in paediatric central nervous system tumours. Hum Genet. 1995 Dec;96(6):684–690. doi: 10.1007/BF00210300. [DOI] [PubMed] [Google Scholar]
  31. Pinkel D., Landegent J., Collins C., Fuscoe J., Segraves R., Lucas J., Gray J. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9138–9142. doi: 10.1073/pnas.85.23.9138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Reardon D. A., Michalkiewicz E., Boyett J. M., Sublett J. E., Entrekin R. E., Ragsdale S. T., Valentine M. B., Behm F. G., Li H., Heideman R. L. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res. 1997 Sep 15;57(18):4042–4047. [PubMed] [Google Scholar]
  33. Schofield D., West D. C., Anthony D. C., Marshal R., Sklar J. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas. Am J Pathol. 1995 Feb;146(2):472–480. [PMC free article] [PubMed] [Google Scholar]
  34. Schröck E., Thiel G., Lozanova T., du Manoir S., Meffert M. C., Jauch A., Speicher M. R., Nürnberg P., Vogel S., Jänisch W. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol. 1994 Jun;144(6):1203–1218. [PMC free article] [PubMed] [Google Scholar]
  35. Schütz B. R., Scheurlen W., Krauss J., du Manoir S., Joos S., Bentz M., Lichter P. Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosomes Cancer. 1996 Jul;16(3):196–203. doi: 10.1002/(SICI)1098-2264(199607)16:3<196::AID-GCC7>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  36. Sozzi G., Tornielli S., Tagliabue E., Sard L., Pezzella F., Pastorino U., Minoletti F., Pilotti S., Ratcliffe C., Veronese M. L. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res. 1997 Dec 1;57(23):5207–5212. [PubMed] [Google Scholar]
  37. Tait D. M., Thornton-Jones H., Bloom H. J., Lemerle J., Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer. 1990 Apr;26(4):464–469. [PubMed] [Google Scholar]
  38. Tomlinson F. H., Scheithauer B. W., Jenkins R. B. Medulloblastoma: II. A pathobiologic overview. J Child Neurol. 1992 Jul;7(3):240–252. doi: 10.1177/088307389200700302. [DOI] [PubMed] [Google Scholar]
  39. Vorechovský I., Tingby O., Hartman M., Strömberg B., Nister M., Collins V. P., Toftgård R. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours. Oncogene. 1997 Jul 17;15(3):361–366. doi: 10.1038/sj.onc.1201340. [DOI] [PubMed] [Google Scholar]
  40. Wolter M., Reifenberger J., Sommer C., Ruzicka T., Reifenberger G. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1997 Jul 1;57(13):2581–2585. [PubMed] [Google Scholar]
  41. Wong W. T., Carlomagno F., Druck T., Barletta C., Croce C. M., Huebner K., Kraus M. H., Di Fiore P. P. Evolutionary conservation of the EPS8 gene and its mapping to human chromosome 12q23-q24. Oncogene. 1994 Oct;9(10):3057–3061. [PubMed] [Google Scholar]
  42. Xiao G. H., Jin F., Klein-Szanto A. J., Goodrow T. L., Linehan M. W., Yeung R. S. The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers. Am J Pathol. 1997 Dec;151(6):1541–1547. [PMC free article] [PubMed] [Google Scholar]
  43. Zerbini C., Gelber R. D., Weinberg D., Sallan S. E., Barnes P., Kupsky W., Scott R. M., Tarbell N. J. Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol. 1993 Apr;11(4):616–622. doi: 10.1200/JCO.1993.11.4.616. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES